○Yuchen Sun 1, Tomomi Furihata 1, Manami Harada 1, Osamu Shimozato 2, Hiroaki Souda 3, Nobuhiro Takiguchi 3, Yoshihiro Nabeya 3, Takehiko Kamijo 4, Naoto Yamaguchi 5, Kan Chiba 1 (1.Laboratory of Pharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Chiba University, 2.Laboratory of DNA Damage Signaling, Chiba Cancer Center Research Institute, 3.Department of Gastrointestinal Surgery, Chiba Cancer Center Hospital, 4.Division of Biochemistry and Molecular Carcinogenesis, Chiba Cancer Center Research Institute, 5.Laboratory of Molecular Cell Biology, Graduate School of Pharmaceutical Sciences, Chiba University)
Session information
1st Predoctoral Symposium for Front-Line Scientists
次世代の革新的薬物動態研究へのアプローチ
Fri. Nov 13, 2015 4:00 PM - 6:00 PM Room E (2F Zuiun)
Organizers:Takumi Tomono(Laboratory of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Takasaki University of Health and Welfare), Yutaro Hoshi(Division of Membrane Transport and Drug Targeting, Graduate School of Pharmaceutical Sciences, Tohoku University), Chairs:Armania Nurdin(Division of Membrane Transport and Drug Targeting, Graduate school of Pharmaceutical Science, Tohoku University), Takeshi Susukida(The Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Science, Chiba University), Akira Katsube(Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical science, The University of Tokyo), Takahito Furuya(Department of Biopharmaceutics School of Pharmacy Tokyo University of Pharmacy and Life Science), Takumi Tomono(Laboratory of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Takasaki University of Health and Welfare), Yutaro Hoshi(Division of Membrane Transport and Drug Targeting, Graduate School of Pharmaceutical Sciences, Tohoku University)
○Masataka Nakano , Tatsuki Fukami , Saki Gotoh , Miki Nakajima (Faculty of Pharmaceutical Sciences, Kanazawa University)
○Saki Noguchi , Tomohiro Nishimura , Masatoshi Tomi , Emi Nakashima (Division of Pharmaceutics, Faculty of Pharmacy, Keio University)
○Hiroaki Shimada , Takeo Nakanishi , Yoshinobu Nakamura , Shio Maruyama , Ikumi Tamai (Department of Membrane Transport and Biopharmaceutics, Graduate School of Medical Sciences, Kanazawa University)
○Kiyomi Ito (Research Institute of Pharmaceutical Science, Musashino University)